Identification of novel circulating miRNAs biomarkers for healthy obese and lean children

Feifei Ma1,2, Dingding Cao1, Zhuo Liu1

  • 1Department of Biochemistry and Immunology, Capital Institute of Pediatrics, 2 Yabao street, Beijing, 100020, People's Republic of China.

BMC Endocrine Disorders
|October 31, 2023
PubMed

Insights

Childhood obesity is rising globally. This study identified specific circulating microRNAs (miRNAs), hsa-miR-15b-5p and hsa-miR-223-3p, as potential biomarkers for early detection of pediatric obesity and associated metabolic risks.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biomarker Discovery

Background:

  • Global rise in childhood obesity and overweight cases.
  • Associated increase in metabolic disorders among children.
  • Complex etiology involving genetic, epigenetic, and environmental factors.

Purpose of the Study:

  • Identify circulating microRNAs (miRNAs) as potential biomarkers for pediatric obesity.
  • Investigate the correlation between specific miRNAs and obesity in children.
  • Explore the role of miRNAs in underlying metabolic abnormalities.

Main Methods:

  • Plasma miRNA expression profiling using miRNA microarrays in obese and lean children.
  • Validation of differentially expressed miRNAs via TaqMan quantitative real-time PCR (qPCR).
  • Statistical analysis including multiple linear regression, ROC curve analysis, and odds ratio calculations.
  • Bioinformatic identification of miRNA target genes and pathway analysis.

Main Results:

  • Thirty-six differentially expressed miRNAs identified; seven validated by qPCR.
  • Upregulation of hsa-miR-15b-5p and hsa-miR-223-3p confirmed, showing significant association with obesity.
  • These miRNAs demonstrated strong diagnostic potential (AUC up to 0.929) and correlated with obesity risk.
  • hsa-miR-15b-5p targets genes in key metabolic pathways like insulin and AMPK signaling.

Conclusions:

  • Circulating miRNA expression profiles reflect metabolic abnormalities in obese children.
  • Hsa-miR-15b-5p and hsa-miR-223-3p show promise as molecular markers for screening obese children.
  • These miRNAs could aid in identifying populations at risk for metabolic syndrome.
Abstract